55 related articles for article (PubMed ID: 3259531)
1. Osteocalcin levels in Cushing's disease before and after treatment.
Sartorio A; Ambrosi B; Colombo P; Morabito F; Faglia G
Horm Metab Res; 1988 Jan; 20(1):70. PubMed ID: 3259531
[No Abstract] [Full Text] [Related]
2. [Basal serum osteocalcin in diseases associated with changes in bone metabolism].
León M; Larrodera L; Solís JA; Hawkins F
Med Clin (Barc); 1987 Jan; 88(3):90-2. PubMed ID: 3493401
[No Abstract] [Full Text] [Related]
3. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
4. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pituitary Cushing's disease: results of adrenal and pituitary surgery.
Pelkonen R; Eistola P; Grahne B; Kuusisto A; Paetau A; Sivula A; Valtonen S
Acta Endocrinol Suppl (Copenh); 1983; 251():38-46. PubMed ID: 6301188
[No Abstract] [Full Text] [Related]
6. [Osteocalcin. Biochemistry, physiology, normal levels and in different pathologies].
de la Piedra C; Toural V; Rapado A
Rev Clin Esp; 1987 Sep; 181(4):213-22. PubMed ID: 3313558
[No Abstract] [Full Text] [Related]
7. Problems in management of Cushing's disease.
Morán C; Flores M; Vázquez C; Zárate A; Loyo M; Klériga E
Arch Invest Med (Mex); 1985; 16(1):19-28. PubMed ID: 4015296
[No Abstract] [Full Text] [Related]
8. Alteration of plasma glucagon response to arginine after treatment in patients with diabetes mellitus, cushing's syndrome and hypothyroidism.
Seino Y; Goto Y; Kurahachi H; Sakurai H; Ikeda M
Horm Metab Res; 1977 Jan; 9(1):28-32. PubMed ID: 844789
[TBL] [Abstract][Full Text] [Related]
9. Modifications in bone-GLA protein (BGP) and aminoterminal propeptide of type III procollagen (PIIINP) levels in one patient with Cushing's syndrome.
Sartorio A; Ambrosi B; Conti A; Monzani M; Faglia G
Horm Metab Res; 1991 May; 23(5):247-9. PubMed ID: 1651897
[No Abstract] [Full Text] [Related]
10. Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
Hunter PR; Ross W; Hall R; Cook DB
Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1225. PubMed ID: 4375290
[No Abstract] [Full Text] [Related]
11. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.
Ambrosi B; Sartorio A; Pizzocaro A; Passini E; Bottasso B; Federici A
Exp Clin Endocrinol Diabetes; 2000; 108(4):294-8. PubMed ID: 10961361
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol.
Jeffcoate WJ; Silverstone JT; Edwards CR; Besser GM
Q J Med; 1979 Jul; 48(191):465-72. PubMed ID: 542586
[TBL] [Abstract][Full Text] [Related]
13. Markers of vascular function in hypertension due to Cushing's syndrome.
Zacharieva S; Atanassova I; Nachev E; Orbetzova M; Kirilov G; Kalinov K; Shigarminova R
Horm Metab Res; 2005 Jan; 37(1):36-9. PubMed ID: 15702437
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of Cushing's disease at Duke University (1977-1982).
Burch WM
N C Med J; 1983 May; 44(5):293-6. PubMed ID: 6575257
[No Abstract] [Full Text] [Related]
15. Cushing's syndrome and serum calcium-albumin interaction.
Leme CE; Wajchenberg BL; Leme PR; Cesar FP
Horm Metab Res; 1977 Mar; 9(2):166. PubMed ID: 16819
[No Abstract] [Full Text] [Related]
16. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
[TBL] [Abstract][Full Text] [Related]
17. Bilateral and simultaneous sinus petrosus inferior catheterization in patients with Cushing's syndrome: plasma-immunoreactive-ACTH-concentrations before and after administration of CRF.
Schulte HM; Allolio B; Günther RW; Benker G; Windeck R; Winkelmann W; Reinwein D
Horm Metab Res Suppl; 1987; 16():66-7. PubMed ID: 2832295
[TBL] [Abstract][Full Text] [Related]
18. Petrosal sinus sampling in the diagnosis of Cushing's syndrome: preliminary experience in University of Malaya Medical Centre.
Norlisah R; Abdullah BJ; Hew FL; Chan SP
Med J Malaysia; 2003 Jun; 58(2):180-6. PubMed ID: 14569737
[TBL] [Abstract][Full Text] [Related]
19. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
20. Cushing's Syndrome.
Pivonello R; De Martino MC; De Leo M; Lombardi G; Colao A
Endocrinol Metab Clin North Am; 2008 Mar; 37(1):135-49, ix. PubMed ID: 18226734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
